# Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS

> **NCT02191215** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 442 (actual)

## Conditions studied

- Acquired Immunodeficiency Syndrome

## Interventions

- **DRUG:** Nevirapine (Viramune®)

## Key facts

- **NCT ID:** NCT02191215
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2004-05
- **Final completion:** —
- **Target enrollment:** 442 (ACTUAL)
- **Last updated:** 2014-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02191215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02191215, "Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02191215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*